ES2099772T3 - Utilizacion de nadh o nadph contra el cancer o el sida. - Google Patents
Utilizacion de nadh o nadph contra el cancer o el sida.Info
- Publication number
- ES2099772T3 ES2099772T3 ES92113288T ES92113288T ES2099772T3 ES 2099772 T3 ES2099772 T3 ES 2099772T3 ES 92113288 T ES92113288 T ES 92113288T ES 92113288 T ES92113288 T ES 92113288T ES 2099772 T3 ES2099772 T3 ES 2099772T3
- Authority
- ES
- Spain
- Prior art keywords
- nadh
- nadph
- aids
- against cancer
- adenine dinucleotide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 title abstract 4
- 208000030507 AIDS Diseases 0.000 title abstract 2
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- 201000011510 cancer Diseases 0.000 title abstract 2
- ACFIXJIJDZMPPO-NNYOXOHSSA-N NADPH Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](OP(O)(O)=O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 ACFIXJIJDZMPPO-NNYOXOHSSA-N 0.000 title 1
- XJLXINKUBYWONI-NNYOXOHSSA-N NADP zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-NNYOXOHSSA-N 0.000 abstract 2
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 abstract 1
- 229950006238 nadide Drugs 0.000 abstract 1
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- AIDS & HIV (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
Abstract
UTILIZACION DE NICOTINAMIDA H), NICOTINAMIDA UNAS SALES DE LOS MISMOS FISIOLOGICAMENTE TOLERABLES, PARA EL TRATAMIENTO DEL CANCER O DEL SIDA.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4128625A DE4128625A1 (de) | 1991-08-26 | 1991-08-26 | Medikament gegen krebs und aids |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2099772T3 true ES2099772T3 (es) | 1997-06-01 |
Family
ID=6439356
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES92113288T Expired - Lifetime ES2099772T3 (es) | 1991-08-26 | 1992-08-04 | Utilizacion de nadh o nadph contra el cancer o el sida. |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0534097B1 (es) |
| JP (1) | JP3493202B2 (es) |
| AT (1) | ATE150313T1 (es) |
| AU (1) | AU653619B2 (es) |
| BR (1) | BR9203302A (es) |
| CA (1) | CA2072484C (es) |
| DE (2) | DE4128625A1 (es) |
| DK (1) | DK0534097T3 (es) |
| ES (1) | ES2099772T3 (es) |
| GR (1) | GR3023191T3 (es) |
| HU (1) | HUT61895A (es) |
| NO (1) | NO300915B1 (es) |
| ZA (1) | ZA924902B (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999012951A1 (en) * | 1997-09-11 | 1999-03-18 | Oxigene, Inc. | Uses of nicotinamide adenine dinucleotide and its analogs for treatment of malignant and infectious diseases |
| US20040126751A1 (en) * | 2002-12-27 | 2004-07-01 | Birkmayer Jorg G.D. | Method of prolonging the life-span of living cells using NADH, NADPH and ADP-ribose |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1162938B (it) * | 1983-08-26 | 1987-04-01 | Dino Spisni | Composizione per la cura dei tumori maligni in particolare sugli animali |
| EP0331620B1 (de) * | 1988-03-01 | 1993-08-11 | Birkmayer, Walther, Prof. Dr. | Mittel zur Behandlung des Parkinson-Syndroms |
-
1991
- 1991-08-26 DE DE4128625A patent/DE4128625A1/de active Granted
-
1992
- 1992-06-26 CA CA002072484A patent/CA2072484C/en not_active Expired - Fee Related
- 1992-07-01 ZA ZA924902A patent/ZA924902B/xx unknown
- 1992-08-04 ES ES92113288T patent/ES2099772T3/es not_active Expired - Lifetime
- 1992-08-04 AT AT92113288T patent/ATE150313T1/de not_active IP Right Cessation
- 1992-08-04 EP EP92113288A patent/EP0534097B1/de not_active Expired - Lifetime
- 1992-08-04 DE DE59208223T patent/DE59208223D1/de not_active Expired - Fee Related
- 1992-08-04 DK DK92113288.2T patent/DK0534097T3/da active
- 1992-08-24 BR BR929203302A patent/BR9203302A/pt not_active Application Discontinuation
- 1992-08-24 JP JP22394492A patent/JP3493202B2/ja not_active Expired - Fee Related
- 1992-08-25 NO NO923324A patent/NO300915B1/no unknown
- 1992-08-25 AU AU21253/92A patent/AU653619B2/en not_active Ceased
- 1992-08-25 HU HU9202739A patent/HUT61895A/hu unknown
-
1997
- 1997-04-21 GR GR970400851T patent/GR3023191T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA924902B (en) | 1993-04-28 |
| NO923324L (no) | 1993-03-01 |
| HUT61895A (en) | 1993-03-29 |
| EP0534097A3 (en) | 1993-07-14 |
| ATE150313T1 (de) | 1997-04-15 |
| JPH072678A (ja) | 1995-01-06 |
| AU2125392A (en) | 1993-03-04 |
| DE59208223D1 (de) | 1997-04-24 |
| NO300915B1 (no) | 1997-08-18 |
| EP0534097A2 (de) | 1993-03-31 |
| CA2072484C (en) | 2002-02-26 |
| BR9203302A (pt) | 1993-03-30 |
| JP3493202B2 (ja) | 2004-02-03 |
| NO923324D0 (no) | 1992-08-25 |
| DE4128625A1 (de) | 1993-04-08 |
| AU653619B2 (en) | 1994-10-06 |
| GR3023191T3 (en) | 1997-07-30 |
| DE4128625C2 (es) | 1993-08-12 |
| DK0534097T3 (da) | 1997-09-22 |
| EP0534097B1 (de) | 1997-03-19 |
| CA2072484A1 (en) | 1993-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA26890C2 (uk) | Піримідиhові похідhі, що мають гербіцидhу активhість, спосіб їх отримаhhя, гербіцидhа композиція і спосіб зhищеhhя бур'яhів | |
| ES2051641A1 (es) | Procedimientos para la preparacion de compuestos derivados de tiourea. | |
| EP1164133A3 (en) | Enantiomerically pure Beta-D-(-)-dioxolane-nucleosides | |
| AU1642795A (en) | Substituted pyridylpyrazoles | |
| NO933321D0 (no) | Nadh og nadph som legemiddel til behandling av mobus alzheimer | |
| ZA913033B (en) | N-(3-fluoro-2-phosphonylmethoxypropyl)derivatives of purine and pyrimidine heterocyclic basis,their preparation and use | |
| WO1999012951A8 (en) | Uses of nicotinamide adenine dinucleotide and its analogs for treatment of malignant and infectious diseases | |
| ES2099772T3 (es) | Utilizacion de nadh o nadph contra el cancer o el sida. | |
| EA199800869A1 (ru) | Лечение угрей | |
| AU9010991A (en) | Antidepressant | |
| ES2066897T3 (es) | 5,11-dihidro-6h-pirido(2,3-b)(1,4)benzodiazepin-6-onas y -tionas y su uso en la prevencion o el tratamiento del sida. | |
| MY103748A (en) | A new antitumor agent obtained by microbial stereoselective reduction of 4-deoxy-4-iododoxorubicin | |
| NO930315L (no) | Fosfenoksidterminerte allen-en-yn dna-spaltende, antitumor- og antimikrobielle midler |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 534097 Country of ref document: ES |